Corporate Banner
Satellite Banner
Automation & Microfluidics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Scientists Close in on Genes Responsible for Parkinson’s Disease

Published: Monday, December 19, 2005
Last Updated: Monday, December 19, 2005
Bookmark and Share
Findings could help doctors predict the likelihood of the disease developing, and provide targets for new treatments.

Scientists have identified 570 genes that act abnormally during the development of Parkinson’s Disease, a finding which could help doctors predict the likelihood of it developing, and provide targets for new treatments.

The research published in Neurogenetics, by the team from Imperial College London and the University of Liege, Belgium, uses microarrays to analyze brains from Parkinson’s patients.

Microarrays are laboratory chips able to pick out which genes are active when different processes are occurring in the brain. When they analyzed brains from people with Parkinson’s, they found that out of all 25,000 human genes, regulation of 570 was highly abnormal in Parkinson’s brains compared with non-diseased brains.

The researchers analyzed 23 brains from recently deceased patients, 15 affected by Parkinson’s and 8 control brains. The majority of brains were provided by the UK Parkinson’s Disease Society Tissue Bank at Imperial College London.

Dr Linda Moran from Imperial College London and one of the authors of the paper, said: “This research shows there are a considerable number of genes associated with the development of Parkinson’s, potentially providing new clues for how to treat this disease. Now that we can identify these genes it may be possible to develop new therapies to help the increasing numbers of Parkinson’s patients.”

The team, led by Professor Manuel Graeber, analyzed two parts of the brain which are affected by neurodegeneration in Parkinson’s; the substantia nigra in the mid-brain, and the cerebral cortex. They were able to eliminate around 15,000 genes from any role in Parkinson’s, as they were not found to be active in the substantia nigra, the part of the brain most affected by Parkinson’s.

Dawn Duke, MS, from Imperial College London, and one of the authors of the paper said: “In addition to identifying those genes linked with the development of Parkinson’s, this research has also shown that many of these genes were especially active in Parkinson’s brains. By limiting the activity of these genes, we may be able to control or even stop the development of Parkinson’s.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

New Clues to How Bacteria Evade Antibiotics
Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics.
Friday, January 10, 2014
Digital 'Plaster' for Monitoring Vital Signs Undergoes First Clinical Trials
ICL researchers are trying out a wireless digital ‘plaster’ that can monitor vital signs continuously and remotely in patients and healthy volunteers.
Thursday, November 05, 2009
On-the-spot DNA Analysis to Test Tolerance to Prescription Drugs Gets Closer
A handheld device to predict whether patients will respond adversely to medication is one step closer to the market.
Tuesday, February 17, 2009
Scientific News
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Releasing Cancer Cells for Better Analysis
A new device developed at the University of Michigan could provide a non-invasive way to monitor the progress of an advanced cancer treatment.
Lab-on-a-Chip for Detecting Glucose
By integrating microfluidic chips with fiber optic biosensors, researchers in China are creating ultrasensitive lab-on-a-chip devices to detect glucose levels.
Soy Shows Promise as Natural Anti-Microbial Agent
Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne illnesses, according to a new study from University of Guelph researchers.
Soy Shows Promise as Natural Anti-Microbial Agent
Researchers from University of Guelph show that soy isoflavones and peptides could be used to reduce microbial contamination of food.
Parsortix Demonstrates Benefits Over Marker-Based Systems
Research published online in the International Journal of Cancer, shows the ParsortixTM System efficiently captures and harvests intact, viable circulating tumour cells (CTCs), including EpCAM-negative CTCs, to allow for broader downstream CTC analysis.
Experimental Therapy For Brain Cancer Could Prevent Drug Resistance
Information from penny-sized microfluidic chips allowed researchers to anticipate resistance to cancer treatment.
3D Printing of Lego Fluidics
Study shows how 3D printing can open up microfluidic technology to a wider audience.
New Method to Preserve Device to Monitor HIV Treatment
Inspired by pregnancy tests, scientists have developed a method to store microfluidic devices for months without refrigeration, giving developing countries an inexpensive and reliable way to treat patients.
Migration Creates Cancer Cell Vulnerabilities
Scientists found that migration can damage cancer cells’ nuclei and DNA, requiring repairs for their survival. The results may open new avenues for targeting metastatic cancer.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!